文献速递关节外科

短效椎管内麻醉药用于全关节置换术的系统综述与网状Meta分析

Short-Acting Spinal Anesthetics for Total Joint Arthroplasty: A Systematic Review and Network Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2026-07-16

该系统综述与网状Meta分析纳入16项研究共1914例患者,比较布比卡因、甲哌卡因、氯普鲁卡因、利多卡因及利多卡因混合液在初次全髋或全膝关节置换术中的恢复特征。短效药与布比卡因相比可缩短住院时间,甲哌卡因和利多卡因术后尿潴留率更低,甲哌卡因总体恢复特征最优。

要点

  • 短效椎管内麻醉药较布比卡因与全髋/全膝置换术后住院时间缩短相关。
  • 甲哌卡因和利多卡因与术后尿潴留率降低相关(甲哌卡因OR 0.20,利多卡因OR 0.51)。
  • 利多卡因与一过性神经症状更频繁相关,甲哌卡因和氯普鲁卡因未见此关联。

核心结论

  • 短效椎管内麻醉药与布比卡因相比与恢复效率改善和术后尿潴留率降低相关。
  • 甲哌卡因在网状Meta分析中各结局指标排序中显示最有利的总体恢复特征。

研究设计与样本

  • 纳入16项随机和比较性研究,共1914例接受初次全髋或全膝关节置换术的患者。
  • 采用随机效应成对Meta分析(限制性最大似然估计,Hartung-Knapp校正)和频率学网状Meta分析整合直接与间接比较。
  • 偏倚风险采用RoB 2和ROBINS-I评估,证据确定性采用GRADE评估。

主要发现

  • 在全髋关节置换术中,短效椎管内麻醉药与布比卡因相比住院时间平均差异为-293.8分钟(95%CI -614.77至27.15;P=0.07)。
  • 在全膝关节置换术中,短效椎管内麻醉药与布比卡因相比住院时间平均差异为-81.6分钟(95%CI -167.02至3.79;P=0.06)。
  • 甲哌卡因与术后尿潴留降低相关(OR 0.20;95%CI 0.09至0.44;P<0.001),利多卡因亦相关(OR 0.51;95%CI 0.34至0.77;P=0.001)。
  • 两种手术中术后恶心呕吐或再入院率未见显著差异。
  • 利多卡因与一过性神经症状更频繁相关,甲哌卡因或氯普鲁卡因未见此关联。

关键数值与推荐

  • 全髋关节置换术住院时间平均差异-293.8分钟(95%CI -614.77至27.15;P=0.07)。
  • 全膝关节置换术住院时间平均差异-81.6分钟(95%CI -167.02至3.79;P=0.06)。
  • 甲哌卡因术后尿潴留OR 0.20(95%CI 0.09至0.44;P<0.001)。
  • 利多卡因术后尿潴留OR 0.51(95%CI 0.34至0.77;P=0.001)。
  • 证据等级:Level II,系统综述与网状Meta分析。

临床怎么用

  • 在当代快速康复路径下,可考虑将麻醉持续时间作为全髋和全膝关节置换术后早期恢复的重要影响因素。
  • 甲哌卡因在总体恢复特征上显示最有利的排序,可结合患者情况优先考虑。

局限性

  • 住院时间差异的置信区间跨越无效线且P值未达显著(全髋P=0.07,全膝P=0.06)。
  • 一过性神经症状在利多卡因中更频繁,选择时需权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As total hip arthroplasty (THA) and total knee arthroplasty (TKA) increasingly shift toward outpatient and short-stay care, recovery milestones such as ambulation and bladder function have become critical determinants of discharge readiness. Although spinal anesthesia is widely used in total joint arthroplasty, the relative recovery profiles of commonly used intrathecal agents remain incompletely defined. METHODS: A systematic review and network meta-analysis were conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. PubMed, Embase, Web of Science, and Scopus were searched through October 2025 for randomized and comparative studies evaluating spinal anesthetics in primary THA or TKA. Random-effects pairwise meta-analyses were performed using restricted maximum likelihood estimation with Hartung-Knapp adjustment. A frequentist network meta-analysis integrated direct and indirect comparisons among bupivacaine, mepivacaine, chloroprocaine, lidocaine, and lidocaine-based mixtures. Risk of bias was assessed using Risk of Bias 2 and Risk Of Bias In Non-randomized Studies of Interventions , and certainty of evidence was evaluated using Grading of Recommendations Assessment, Development and Evaluation. There were 16 studies encompassing 1,914 patients that met inclusion criteria. RESULTS: In THA, short-acting spinal anesthetics were associated with a reduction in lengths of stay compared with bupivacaine (mean difference -293.8 minutes; 95% confidence interval (CI) -614.77 to 27.15; P = 0.07). In TKA, a smaller but consistent reduction in length of stay was observed (mean difference -81.6 minutes; 95% CI -167.02 to 3.79; P = 0.06). Rates of postoperative urinary retention were lower with mepivacaine and lidocaine in both THA and TKA cohorts (mepivacaine odds ratio 0.20; 95% CI, 0.09 to 0.44; P < 0.001; lidocaine odds ratio 0.51; 95% CI 0.34 to 0.77; P = 0.001). There were no significant differences observed in postoperative nausea and vomiting or readmission in either procedure. Transient neurologic symptoms were more frequent with lidocaine, but not with mepivacaine or chloroprocaine. Network meta-analysis demonstrated consistent ranking of anesthetic agents across outcomes, with mepivacaine showing the most favorable overall recovery profile. CONCLUSIONS: Short-acting spinal anesthetics were associated with improved recovery efficiency and lower rates of postoperative urinary retention compared with bupivacaine. These findings support consideration of anesthetic duration as an important contributor to early recovery following THA and TKA within contemporary rapid-recovery pathways. LEVEL OF EVIDENCE: Level II, systematic review and network meta-analysis.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Siddiqi A, Yousuf KM, Conrad D, et al. Short-Acting Spinal Anesthetics for Total Joint Arthroplasty: A Systematic Review and Network Meta-Analysis. J Arthroplasty. 2026. PMID: 42462883. doi:10.1016/j.arth.2026.07.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。